Swiss National Bank Reduces Holdings in Avantor, Inc. (NYSE:AVTR)

Swiss National Bank reduced its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 4.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,920,500 shares of the company's stock after selling 95,600 shares during the quarter. Swiss National Bank owned 0.28% of Avantor worth $40,465,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of AVTR. State Street Corp grew its holdings in shares of Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company's stock worth $578,666,000 after purchasing an additional 8,206,695 shares in the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock worth $159,740,000 after purchasing an additional 5,354,678 shares in the last quarter. FMR LLC grew its holdings in shares of Avantor by 557.2% during the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company's stock worth $120,950,000 after purchasing an additional 3,963,912 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Avantor by 18.2% during the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company's stock worth $457,710,000 after purchasing an additional 2,719,615 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Avantor during the 4th quarter worth $33,091,000. 95.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts recently weighed in on AVTR shares. UBS Group reaffirmed a "neutral" rating and issued a $25.00 price objective (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Stifel Nicolaus reduced their price objective on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Cowen reaffirmed a "buy" rating on shares of Avantor in a research note on Tuesday. Raymond James reaffirmed an "outperform" rating and issued a $24.00 price objective (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Finally, Royal Bank of Canada reduced their price objective on Avantor from $33.00 to $31.00 and set an "outperform" rating on the stock in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to MarketBeat.com, Avantor has a consensus rating of "Moderate Buy" and an average target price of $25.50.

Remove Ads

Avantor Trading Down 2.2 %

AVTR stock traded down $0.38 during mid-day trading on Thursday, reaching $16.30. The company's stock had a trading volume of 8,224,660 shares, compared to its average volume of 6,273,731. The company has a market cap of $11.10 billion, a price-to-earnings ratio of 15.67, a price-to-earnings-growth ratio of 1.55 and a beta of 1.30. The business's 50 day moving average price is $19.20 and its 200 day moving average price is $21.84. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a 12 month low of $15.37 and a 12 month high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the company earned $0.22 earnings per share. On average, equities research analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Buying and Selling at Avantor

In other Avantor news, EVP James Bramwell sold 3,758 shares of the business's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares of the company's stock, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Steven W. Eck sold 4,907 shares of the business's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the sale, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.30% of the company's stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.